======= VPS8 =======
== Gene Information ==
* **Official Symbol**: VPS8
* **Official Name**: VPS8 subunit of CORVET complex
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23355|23355]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8N3P4|Q8N3P4]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=VPS8&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20VPS8|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/618366|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Plays a role in vesicle-mediated protein trafficking of the endocytic membrane transport pathway. Believed to act as a component of the putative CORVET endosomal tethering complexes which is proposed to be involved in the Rab5-to-Rab7 endosome conversion probably implicating MON1A/B, and via binding SNAREs and SNARE complexes to mediate tethering and docking events during SNARE-mediated membrane fusion. The CORVET complex is proposed to function as a Rab5 effector to mediate early endosome fusion probably in specific endosome subpopulations (PubMed:25266290). Functions predominantly in APPL1-containing endosomes (PubMed:25266290). {ECO:0000269|PubMed:25266290, ECO:0000305|PubMed:25266290}.
|Vps8|
|CORVET complex|
|endosomal vesicle fusion|
|vesicle fusion|
|organelle membrane fusion|
|organelle fusion|
|membrane fusion|
|early endosome|
|vesicle organization|
|membrane organization|
|protein transport|
|peptide transport|
|amide transport|
|establishment of protein localization|
|nitrogen compound transport|
|vesicle-mediated transport|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-2.26|
|[[:results:exp51|Nifuroxazide 1μM R01 exp51]]|1.71|
|[[:results:exp280|Daidzin 10μM R06 exp280]]|1.76|
|[[:results:exp216|Erlotinib 10μM R05 exp216]]|1.76|
|[[:results:exp390|Pifithrin-alpha 20μM R07 exp390]]|1.96|
|[[:results:exp288|HMS-I2 10μM R06 exp288]]|2.18|
|[[:results:exp301|VER-155008 3.9μM R06 exp301]]|2.19|
^Gene^Correlation^
|[[:human genes:t:tgfbrap1|TGFBRAP1]]|0.476|
|[[:human genes:a:ap2s1|AP2S1]]|0.455|
|[[:human genes:v:vps45|VPS45]]|0.447|
|[[:human genes:r:rab5c|RAB5C]]|0.427|
|[[:human genes:c:cyb561a3|CYB561A3]]|0.402|
Global Fraction of Cell Lines Where Essential: 1/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|1/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 1967
* **Expression level (log2 read counts)**: 5.34
{{:chemogenomics:nalm6 dist.png?nolink |}}